Evaluating Landmark Clinical Data for HER2-low Breast Cancer

Project Oncology® - En podkast av ReachMD

Prøv Podimo gratis i hele 60! dager!

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

 Reklame

Host: Pavani Chalasani, MD, MPH Guest: Prof. David Cameron A groundbreaking clinical study on patients with HER2-low breast cancer may impact they way we provide treatment. Dr. David Cameron from the University of Edinburgh in Scotland joins Dr. Pavanai Chalasani to share key results from the DESTINY Breast04 trial.

Visit the podcast's native language site